# PharmacoEconomic Assessment IRESSA® in the Treatment of Non-Small-Cell Lung Cancer (NSCLC)

> **NCT00173524** · — · UNKNOWN · sponsor: **National Taiwan University Hospital** · enrollment: 200 (estimated)

## Conditions studied

- Non-Small Cell Lung Cancer

## Interventions

- **BEHAVIORAL:** PharmacoEconomic Assessment

## Key facts

- **NCT ID:** NCT00173524
- **Lead sponsor:** National Taiwan University Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2005-09
- **Primary completion:** —
- **Final completion:** 2005-09
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2009-05-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00173524

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00173524, "PharmacoEconomic Assessment IRESSA® in the Treatment of Non-Small-Cell Lung Cancer (NSCLC)". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00173524. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*